.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Cipla
UBS
Accenture
US Army
Cantor Fitzgerald
Colorcon
Boehringer Ingelheim
Healthtrust
Mallinckrodt

Generated: July 27, 2017

DrugPatentWatch Database Preview

TRIAMCINOLONE Drug Profile

« Back to Dashboard

Which patents cover Triamcinolone, and what generic Triamcinolone alternatives are available?

Triamcinolone is a drug marketed by Sandoz, Mylan, Roxane, Barr, Purepac Pharm, Watson Labs, Impax Labs, Ivax Sub Teva Pharms, Teva, Mylan Pharms Inc, Taro, Parnell, Perrigo Israel, Teligent Pharma Inc, Pharmafair, Akorn, Perrigo New York, Alpharma Us Pharms, Glenmark Pharms Ltd, G And W Labs Inc, Ambix, Wockhardt Eu Operatn, Wockhardt, Lupin Atlantis, Sandoz Inc, Fougera Pharms, Vintage, Lyne, Topiderm, Perrigo Uk Finco, Pharmaderm, Morton Grove, G And W Labs, Actavis Mid Atlantic, and Cmp Pharma Inc. and is included in ninety-four NDAs.

The generic ingredient in TRIAMCINOLONE is triamcinolone diacetate. There are fifty-one drug master file entries for this compound. Additional details are available on the triamcinolone diacetate profile page.

Summary for Tradename: TRIAMCINOLONE

Patents:0
Applicants:35
NDAs:94
Bulk Api Vendors: see list40
Clinical Trials: see list234
Patent Applications: see list6,658
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRIAMCINOLONE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
OINTMENT;TOPICAL040386-001Jun 5, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Mid Atlantic
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
OINTMENT;TOPICAL087799-001Jun 7, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Taro
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
CREAM;TOPICAL040038-001Oct 26, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Perrigo New York
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
CREAM;TOPICAL086415-001Approved Prior to Jan 1, 1982ATRXNoNo► Subscribe► Subscribe► Subscribe
Pharmaderm
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
CREAM;TOPICAL087992-001Jul 7, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Chubb
Johnson and Johnson
Accenture
Federal Trade Commission
Julphar
Cipla
Covington
Mallinckrodt
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot